Annual Report 2021

NOTESTOTHE CONSOLIDATED FINANCIAL STATEMENTS For the year ended 31 December 2021 137 The United Laboratories International Holdings Limited Annual Report 2021 38. FINANCIAL INSTRUMENTS (Continued) Financial risk management objectives and policies (Continued) Credit risk and impairment assessment (Continued) The tables below detail the credit risk exposures of the Group’s financial assets at 31 December 2021 and 2020 which are subject to ECL assessment: External Internal Gross credit credit 12m or carrying 2021 Notes rating rating lifetime ECL amount RMB’000 Pledged bank deposits 24 A1 to Ba1 N/A 12m ECL 827,389 Other pledged deposits 28 A2 to A3 N/A 12m ECL 24,000 Bank balances 24 Aa1 to Ba1 N/A 12m ECL 3,330,867 Other receivables and deposits 23 N/A Note 1 12m ECL 125,431 Consideration receivables 23 N/A Note 4 Lifetime ECL (credit-impaired) 339,574 Bills receivables 23 A1 to B1 N/A 12m ECL 1,821,768 Trade receivables 23 N/A Note 2 Lifetime ECL (provision matrix) 1,624,198